{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T07:40:06Z","timestamp":1792309206101,"version":"4.4.0"},"reference-count":56,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Pfizer Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14760584.2026.2748741","type":"journal-article","created":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:57:41Z","timestamp":1792306661000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["The socioeconomic value of adult respiratory vaccination in Australia: a benefit-cost analysis"],"prefix":"10.1080","volume":"25","author":[{"given":"Matthew","family":"Napier","sequence":"first","affiliation":[{"name":"Office of Health Economics","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus","family":"Macfarlane","sequence":"additional","affiliation":[{"name":"Office of Health Economics","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Tunnicliffe","sequence":"additional","affiliation":[{"name":"Office of Health Economics","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Brassel","sequence":"additional","affiliation":[{"name":"Office of Health Economics","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Cahill","sequence":"additional","affiliation":[{"name":"Pfizer Australia Pty"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Ryan","sequence":"additional","affiliation":[{"name":"Pfizer Australia Pty"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Lohan","sequence":"additional","affiliation":[{"name":"Pfizer Australia Pty"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valda","family":"Struwig","sequence":"additional","affiliation":[{"name":"Pfizer Australia Pty"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Vietri","sequence":"additional","affiliation":[{"name":"Pfizer","place":["Collegeville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Mendes","sequence":"additional","affiliation":[{"name":"Pfizer","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyan","family":"Hu","sequence":"additional","affiliation":[{"name":"Pfizer","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Steuten","sequence":"additional","affiliation":[{"name":"Office of Health Economics","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70015"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060273"},{"key":"e_1_3_4_4_1","unstructured":"Australian Centre for Disease Control. Invasive pneumococcal disease (IPD) [Internet]. Australian centre for disease control. 2025 [cited 2026 Jul 2]. Available from: https:\/\/www.cdc.gov.au\/diseases\/invasive-pneumococcal-disease-ipd"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2024.0011"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70092"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13003"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13131"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13121212"},{"key":"e_1_3_4_10_1","unstructured":"Australian Centre for Disease Control. Australian respiratory surveillance reports \u2013 2025. [Internet]. Australian Centre for Disease Control; 2026 [cited 2026 Apr 29]. Available from: https:\/\/www.cdc.gov.au\/resources\/collections\/arsr-2025"},{"key":"e_1_3_4_11_1","unstructured":"Australian Bureau of Statistics. Deaths due to acute respiratory infections in Australia March 2026 | Australian bureau of statistics [Internet]. 2026 [cited 2026 May 1]. Available from: https:\/\/www.abs.gov.au\/statistics\/health\/causes-death\/deaths-due-acute-respiratory-infections-australia\/latest-release"},{"key":"e_1_3_4_12_1","unstructured":"Australian Centre for Disease Control. NNDSS public dataset \u2013 pneumococcal disease (invasive). Internet. Australian Centre for Disease Control; 2025 [cited 2026 May 19]. Available from: https:\/\/www.cdc.gov.au\/resources\/publications\/nndss-dataset-pneumococcal"},{"issue":"68","key":"e_1_3_4_13_1","first-page":"PA3299","article-title":"Seasonality of respiratory viruses and viral co-infection across two winter seasons in the UK","volume":"64","author":"Purcell M","year":"2024","unstructured":"Purcell M, Morelli T, Cox O, et al. Seasonality of respiratory viruses and viral co-infection across two winter seasons in the UK. Eur Respir J [Internet]. 2024 [cited 2026 Apr 28];64(suppl 68):PA3299.","journal-title":"Eur Respir J"},{"key":"e_1_3_4_14_1","unstructured":"Australian Technical Advisory Group on Immunisation. The Australian Immunisation Handbook [Internet]. 2026 [cited 2026 May 19]. Available from: https:\/\/immunisationhandbook.health.gov.au\/"},{"key":"e_1_3_4_15_1","volume-title":"National immunisation strategy for Australia 2025 to 2030","author":"Australian Centre for Disease Control","year":"2025","unstructured":"Australian Centre for Disease Control. National immunisation strategy for Australia 2025 to 2030 [Internet]. Australia: Australian Centre for Disease Control; 2025 [cited 2026 May 1]. [Internet]: https:\/\/www.cdc.gov.au\/resources\/publications\/national-immunisation-strategy-australia-2025-2030"},{"key":"e_1_3_4_16_1","unstructured":"Australian Government Department of Health D and A. HTA review final report collection [internet]. Australian government department of health disability and ageing. 2025 [cited 2026 May 1]. Available from: https:\/\/www.health.gov.au\/resources\/collections\/hta-review-final-report-collection"},{"key":"e_1_3_4_17_1","unstructured":"NCIRS. Annual immunisation coverage report 2025 \u2013 summary [Internet]. 2026 [cited 2026 Jul 9]. Available from: https:\/\/ncirs.org.au\/immunisation-coverage-data-and-reports\/annual-immunisation-coverage-report-2025-summary"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-021-00683-z"},{"key":"e_1_3_4_19_1","unstructured":"Hayes H Darrow B Cookson G et al. Employer costs from respiratory infections: survey data on the business burden [Internet]. 2024 [cited 2024 Dec 20]. Available from: https:\/\/www.ohe.org\/publications\/employer-costs-from-respiratory-infections\/"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4015886"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2025.2536093"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2025.2536092"},{"key":"e_1_3_4_23_1","doi-asserted-by":"crossref","first-page":"2689614","DOI":"10.1080\/14760584.2026.2689614","article-title":"Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit\u2013cost analysis","volume":"25","author":"Tunnicliffe E","year":"2026","unstructured":"Tunnicliffe E, Napier M, Theakston C, et al. Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit\u2013cost analysis. Expert Rev Vaccines. 2026;25(ja):2689614.","journal-title":"Expert Rev Vaccines"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/haschl\/qxag114"},{"key":"e_1_3_4_25_1","doi-asserted-by":"crossref","first-page":"2695495","DOI":"10.1080\/14760584.2026.2695495","article-title":"Evaluating the socioeconomic value of adult respiratory immunization in Spain: a benefit-cost analysis","volume":"25","author":"Napier M","year":"2026","unstructured":"Napier M, L\u00f3pez-Ib\u00e1nez de Aldecoa A, Brassel S, et al. Evaluating the socioeconomic value of adult respiratory immunization in Spain: a benefit-cost analysis. Expert Rev Vaccines. 2026;25(ja):2695495.","journal-title":"Expert Rev Vaccines"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408544"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126567"},{"issue":"6","key":"e_1_3_4_28_1","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1093\/cid\/ciaf061","article-title":"Efficacy, immunogenicity, and safety of the bivalent respiratory syncytial virus (RSV) prefusion F vaccine in older adults over 2 RSV seasons","volume":"81","author":"Walsh EE","year":"2025","unstructured":"Walsh EE, Eiras D, Woodside J, et al. Efficacy, immunogenicity, and safety of the bivalent respiratory syncytial virus (RSV) prefusion F vaccine in older adults over 2 RSV seasons. Clin Infect Dis. 2025;81(6):e680\u2013e689.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2026.101520"},{"key":"e_1_3_4_30_1","unstructured":"CDC. CDC seasonal flu vaccine effectiveness studies [Internet]. 2026 [cited 2026 May 26]. Available from: https:\/\/www.cdc.gov\/flu-vaccines-work\/php\/effectiveness-studies\/index.html"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107249"},{"issue":"5","key":"e_1_3_4_32_1","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/cid\/ciae339","article-title":"Risks of SARS-CoV-2 JN.1 infection and COVID-19-Associated emergency department Visits\/Hospitalizations following updated boosters and prior infection: a population-based cohort study","volume":"79","author":"Chong C","year":"2024","unstructured":"Chong C, Wee LE, Jin X, et al. Risks of SARS-CoV-2 JN.1 infection and COVID-19-Associated emergency department Visits\/Hospitalizations following updated boosters and prior infection: a population-based cohort study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2024;79(5):1190\u20131196.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"e_1_3_4_33_1","article-title":"Early estimates of updated 2023\u20132024 (monovalent XBB.1.5) COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection attributable to Co-circulating omicron variants among immunocompetent adults \u2014 increasing community access to testing program, United States, September 2023\u2013January 2024","volume":"73","author":"Ruth Link-Gelles P","year":"2024","unstructured":"Ruth Link-Gelles P, Allison Avrich Ciesla P, Josephine Mak MPH, et al. Early estimates of updated 2023\u20132024 (monovalent XBB.1.5) COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection attributable to Co-circulating omicron variants among immunocompetent adults \u2014 increasing community access to testing program, United States, September 2023\u2013January 2024. MMWR Morb Mortal Wkly Rep [Internet]. 2024 [cited 2026 July 8];73.","journal-title":"MMWR Morb Mortal Wkly Rep [Internet]"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2025.07.002"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.05.067"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53842-w"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.126881"},{"key":"e_1_3_4_38_1","unstructured":"Office of Impact Analysis. Value of statistical life [internet]. Australian government department of the prime minister and cabinet. 2026 [cited 2026 May 5]. Available from: https:\/\/www.oecd.org\/en\/publications\/mortality-risk-valuation-in-environment-health-and-transport-policies_9789264130807-en.html"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.030"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.04.012"},{"key":"e_1_3_4_41_1","unstructured":"Department of health disability and ageing. COVID-19 vaccination [Internet]. 2026 [cited 2026 May 26]. Available from: https:\/\/www.health.gov.au\/sites\/default\/files\/2026-01\/covid-19-vaccine-rollout-update-1-january-2026.pdf"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-00939-w"},{"key":"e_1_3_4_43_1","unstructured":"World Bank. World Bank Open Data [Internet]. World Bank Open Data. 2025 [cited 2025 Aug 29]. Available from: https:\/\/data.worldbank.org"},{"key":"e_1_3_4_44_1","unstructured":"Australian Government Department of Health. PBAC guidelines | 3A.1 overview and rationale of the economic evaluation [internet]. Australian government department of health and aged care. 2016 [cited 2026 May 8]. Available from: https:\/\/pbac.pbs.gov.au\/section-3a\/3a-1-overview-and-rationale-of-economic-evaluation.html"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/hpja.875"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2026.128395"},{"key":"e_1_3_4_47_1","unstructured":"AIHW. Government expenditure on public health activities in Australia 2023\u201324 about [internet]. Aust. Inst. Health welf. 2025 [cited 2026 Jul 13]. Available from: https:\/\/www.aihw.gov.au\/reports\/health-welfare-expenditure\/government-expenditure-on-public-health-activities\/contents\/about"},{"key":"e_1_3_4_48_1","unstructured":"Australian Government Department of Health. Disability and Ageing. National preventive health strategy 2021\u20132030 [internet]. 2021 [cited 2026 Jul 13]. Available from: https:\/\/www.health.gov.au\/resources\/publications\/national-preventive-health-strategy-2021-2030?language=en"},{"key":"e_1_3_4_49_1","unstructured":"Tunnicliffe E Hayes H O\u2019neill P et al. Analysing global immunisation expenditure. [Internet]. London: Office of Health Economics; 2025. Available from: https:\/\/www.ohe.org\/publications\/analysing-global-immunisation-expenditure\/"},{"key":"e_1_3_4_50_1","unstructured":"Immunisation Coalition. Enhancing Adult Vaccination Coverage Rates in Australia - Immunisation Coalition [Internet]. 2021 [cited 2026 Aug 12]. Available from: https:\/\/immunisationcoalition.org.au\/enhancing-adult-vaccination-coverage-rates-in-australia\/"},{"key":"e_1_3_4_51_1","doi-asserted-by":"crossref","unstructured":"Eichner M Schwehm M Eichner L et al. Direct and indirect effects of influenza vaccination | BMC infectious diseases |. Springer Nature Link [Internet]. 2017 [cited 2026 Jun 1]. Available from: https:\/\/link.springer.com\/article\/10.1186\/s12879-017-2399-4","DOI":"10.1186\/s12879-017-2399-4"},{"key":"e_1_3_4_52_1","doi-asserted-by":"crossref","unstructured":"Lin L Demirhan H Eizenberg P et al. Quantifying the direct and indirect impact of COVID-19 vaccination: evidence from Victoria. Australia [Internet]. arXiv. 2025 [cited 2026 Jun 1]. Available from: http:\/\/arxiv.org\/abs\/2508.08763","DOI":"10.1098\/rsif.2025.0839"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12591-w"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11010071"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00846-2"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00684-9"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13040316"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2026.2748741","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14760584.2026.2748741","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2026.2748741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:57:46Z","timestamp":1792306666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2026.2748741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14760584.2026.2748741"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2026.2748741","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-07-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2748741"}}